非破裂性腹主动脉瘤的治疗结局趋势:一项全国性前瞻性队列研究
EVAR后围手术期死亡率无改善(aOR 1.06,95%CI 0.94-1.20),开放手术后死亡率下降(aOR 0.89,95%CI 0.82-0.98);两组主要并发症均减少,教科书结局(TbO)率均升高。
要点
- EVAR后围手术期死亡率无改善(aOR 1.06,95%CI 0.94-1.20)。
- 开放手术后围手术期死亡率下降(2014年6.1% vs 2019年4.6%;aOR 0.89)。
- EVAR和开放手术后主要并发症均减少且TbO率均升高。
核心结论
- 自全国性质量改进项目(DSAA)建立以来,EVAR和开放手术修复非破裂性腹主动脉瘤的所有结局均有改善,但EVAR后围手术期死亡率保持不变。
研究设计与样本
- 全国性前瞻性队列研究,选自DSAA数据库2014至2019年因非破裂性腹主动脉瘤接受标准EVAR或开放手术初次修复的患者。
主要发现
- EVAR后围手术期死亡率经混杂因素调整后无改善(aOR 1.06,95%CI 0.94-1.20)。
- EVAR后主要并发症减少(2014年10.1% vs 2019年7.0%;aOR 0.91,95%CI 0.88-0.95),TbO率升高(2014年68.1% vs 2019年80.9%;aOR 1.13,95%CI 1.10-1.16)。
- 开放手术后围手术期死亡率下降(2014年6.1% vs 2019年4.6%;aOR 0.89,95%CI 0.82-0.98),主要并发症减少(2014年28.6% vs 2019年23.3%;aOR 0.95,95%CI 0.91-0.99)。
- 开放手术后TbO率升高(2014年49.1% vs 2019年58.3%;aOR 1.05,95%CI 1.01-1.10)。
- EVAR和开放手术组中合并心脏疾病的患者比例均增加。
关键数值与推荐
- EVAR后围手术期死亡率年趋势aOR 1.06(95%CI 0.94-1.20),未达统计学显著。
- 开放手术后围手术期死亡率年趋势aOR 0.89(95%CI 0.82-0.98),达统计学显著。
- EVAR后主要并发症年趋势aOR 0.91(95%CI 0.88-0.95),TbO年趋势aOR 1.13(95%CI 1.10-1.16)。
- 开放手术后主要并发症年趋势aOR 0.95(95%CI 0.91-0.99),TbO年趋势aOR 1.05(95%CI 1.01-1.10)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Dutch Surgical Aneurysm Audit (DSAA) initiative was established in 2013 to monitor and improve nationwide outcomes of aortic aneurysm surgery. The objective of this study was to examine whether outcomes of surgery for intact abdominal aortic aneurysms (iAAA) have improved over time. METHODS: Patients who underwent primary repair of an iAAA by standard endovascular (EVAR) or open surgical repair (OSR) between 2014 and 2019 were selected from the DSAA for inclusion. The primary outcome was peri-operative mortality trend per year, stratified by OSR and EVAR. Secondary outcomes were trends per year in major complications, textbook outcome (TbO), and characteristics of treated patients. The trends per year were evaluated and reported in odds ratios per year. RESULTS: In this study, 11 624 patients (74.8%) underwent EVAR and 3 908 patients (25.2%) underwent OSR. For EVAR, after adjustment for confounding factors, there was no improvement in peri-operative mortality (aOR [adjusted odds ratio] 1.06, 95% CI 0.94 - 1.20), while major complications decreased (2014: 10.1%, 2019: 7.0%; aOR 0.91, 95% CI 0.88 - 0.95) and the TbO rate increased (2014: 68.1%, 2019: 80.9%; aOR 1.13, 95% CI 1.10 - 1.16). For OSR, the peri-operative mortality decreased (2014: 6.1%, 2019: 4.6%; aOR 0.89, 95% CI 0.82 - 0.98), as well as major complications (2014: 28.6%, 2019: 23.3%; aOR 0.95, 95% CI 0.91 - 0.99). Furthermore, the proportion of TbO increased (2014: 49.1%, 2019: 58.3%; aOR 1.05, 95% CI 1.01 - 1.10). In both the EVAR and OSR group, the proportion of patients with cardiac comorbidity increased. CONCLUSION: Since the establishment of this nationwide quality improvement initiative (DSAA), all outcomes of iAAA repair following EVAR and OSR have improved, except for peri-operative mortality following EVAR which remained unchanged.
引用
- Alberga AJ, Karthaus EG, Wilschut JA, et al. Treatment Outcome Trends for Non-Ruptured Abdominal Aortic Aneurysms: A Nationwide Prospective Cohort Study. Eur J Vasc Endovasc Surg. 2022. PMID: 35027275. doi:10.1016/j.ejvs.2021.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。